| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f62b36b442d05acbbbd8a50348777098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f07e110afdf168a2f352b0d934841f9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ea9a5b1016a7be93e2b100637e7fa36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b20bf4e7acb6371d23d34aa573c85847
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8583a90fc8bf96bd36d4bbf9c8320e9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77912719e2a33cb92dd5469a90404348 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-88 |
| filingDate |
2012-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a89cecb0f8ab07efed3f6b26f71dccae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0651c3dcb0c7f4a78a84a625ef3a0615
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fe66ee3ad3affa4db95b3f230c4b9b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e51eb7190bebf18892676a574992305e |
| publicationDate |
2013-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013025508-A1 |
| titleOfInvention |
Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections |
| abstract |
Provided is a process for treating or preventing a viral infection in a subject, wherein the viral infection is from a flavivirus selected from the group consisting of Hepatitis C Virus (genotypes 1-7) and Japanese Encephalitis Virus. The process includes administering to the subject a therapeutically effective amount of at least one compound represented by the formula:(Formula (I)) |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9796687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3095446-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020176652-A1 |
| priorityDate |
2011-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |